Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug aims to douse the fire of menopause for thousands of women

NCT ID NCT07490431

Not yet recruiting Symptom relief Sponsor: Bayer Source: ClinicalTrials.gov ↗

Summary

This study is gathering real-world information on how well a new, non-hormonal medication called elinzanetant works for women experiencing disruptive menopause symptoms like hot flashes and night sweats. Researchers will follow about 1,500 women in the U.S. who are starting this medication as part of their regular doctor's care. The goal is to see how the treatment affects their symptoms, sleep, and daily life over 12 weeks to 2 years, using phone apps and, for some, a smart ring to track sleep.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VASOMOTOR SYMPTOMS (VMS) ASSOCIATED WITH MENOPAUSE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bayer

    Whippany, New Jersey, 07981, United States

Conditions

Explore the condition pages connected to this study.